Literature DB >> 25812480

Role of nociceptin/orphanin FQ in thermoregulation.

Monica Baiula1, Andrea Bedini1, Santi M Spampinato2.   

Abstract

Nociceptin/Orphanin FQ (N/OFQ) is a 17-amino acid peptide that binds to the nociceptin receptor (NOP). N/OFQ and NOP receptors are expressed in numerous brain areas. The generation of specific agonists, antagonists and receptor-deficient mice or rats has enabled progress in elucidating the biological functions of N/OFQ. These tools have been employed to identify the biological significance of the N/OFQ system and how it interacts with other endogenous systems to regulate several body functions. The present review focuses on the role of N/OFQ in the regulation of body temperature and its relationship with energy balance. Critical evaluation of the literature data suggests that N/OFQ, acting through the NOP receptor, may cause hypothermia by influencing the complex thermoregulatory system that operates as a federation of independent thermoeffector loops to control body temperature at the hypothalamic level. Furthermore, N/OFQ counteracts hyperthermia elicited by cannabinoids or µ-opioid agonists. N/OFQ-induced hypothermia is prevented by ω-conotoxin GVIA, an N-type calcium channel blocker. Hypothermia induced by N/OFQ is considered within the framework of the complex action that this neuropeptide exerts on energy balance. Energy stores are regulated through the complex neural controls exerted on both food intake and energy expenditure. In laboratory rodents, N/OFQ stimulates consummatory behavior and decreases energy expenditure. Taken together, these studies support the idea that N/OFQ contributes to the regulation of energy balance by acting as an "anabolic" neuropeptide as it elicits effects similar to those produced in the hypothalamus by other neuropeptides such as orexins and neuropeptide Y.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body temperature; Energy balance; Food intake; Hypothermia; Nociceptin; Opioids

Mesh:

Substances:

Year:  2015        PMID: 25812480     DOI: 10.1016/j.npep.2015.03.005

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  4 in total

1.  The physiological signature of daily torpor is not orexin dependent.

Authors:  Viviana Lo Martire; Chiara Berteotti; Stefano Bastianini; Sara Alvente; Alice Valli; Matteo Cerri; Roberto Amici; Alessandro Silvani; Steven J Swoap; Giovanna Zoccoli
Journal:  J Comp Physiol B       Date:  2020-05-12       Impact factor: 2.200

2.  Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration.

Authors:  Huimei Wei; Ting Zhang; Chang-Guo Zhan; Fang Zheng
Journal:  Neuropharmacology       Date:  2020-05-08       Impact factor: 5.273

3.  Subarachnoid and epidural dexmedetomidine for the prevention of post-anesthetic shivering: a meta-analysis and systematic review.

Authors:  Yi-Zheng Li; Yi Jiang; Han Lin; Xue-Ping Yang
Journal:  Drug Des Devel Ther       Date:  2019-11-01       Impact factor: 4.162

Review 4.  Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders.

Authors:  Massimo Ubaldi; Nazzareno Cannella; Anna Maria Borruto; Michele Petrella; Maria Vittoria Micioni Di Bonaventura; Laura Soverchia; Serena Stopponi; Friedbert Weiss; Carlo Cifani; Roberto Ciccocioppo
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.